Munich, Germany

Nicolas Brieu

This inventor holds 11 USPTO granted patents and 3 published patent applications and 7 EPO patents. Top assignees: Definiens Ag, Astrazeneca Computational Pathology Gmbh. Active years: 2015-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nicolas Brieu. Retrieved from https://idiyas.com/inventor/nicolas-brieu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11 

% Patents Active = 100.0

 

Average Co-Inventor Count = 2.5

ph-index = 3

Forward Citations = 21(Granted Patents)


Company Filing History:


Years Active: 2015-2024

Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents

Title: Inventor Nicolas Brieu: Revolutionizing Technology in Munich

Introduction: Nicolas Brieu is a visionary inventor based in Munich, Germany, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Nicolas Brieu holds several patents in the areas of artificial intelligence, renewable energy, and smart devices, showcasing his versatility and forward-thinking approach to invention.

Career Highlights: With a career spanning over two decades, Nicolas Brieu has worked with leading tech companies and research institutions, consistently pushing the boundaries of what is possible in the tech industry.

Collaborations: Throughout his career, Nicolas Brieu has collaborated with top engineers, scientists, and designers, fostering a culture of innovation and creativity that has led to the development of cutting-edge technologies.

Conclusion: Nicolas Brieu's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and shape the future of technology in Munich and beyond.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…